Letter

·2007

Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking

Altan Onat , Gülay Hergenç YTU

Atherosclerosis

No open-access abstract is available for this article. Use the DOI link on the right to read the full text.

Keywords

Asymmetric dimethylarginine Metabolic syndrome Medicine Internal medicine Cardiology Endocrinology Arginine Chemistry Obesity Biochemistry

Subject Areas

Nitric Oxide and Endothelin Effects ·Physiology ·Health Sciences
Neuroscience of respiration and sleep ·Endocrine and Autonomic Systems ·Life Sciences
Eicosanoids and Hypertension Pharmacology ·Biochemistry ·Life Sciences

Citations by Year

OpenAlex SDG Match

SDGs auto-classified by OpenAlex (score ≥ 0.4 shown).

Good health and well-being 77%

Related Articles

Other articles contributing to the same SDGs.

2026 · 2 citations

Discrete thermal analysis of the E–type shell–and–tube heat exchanger

Scientific Reports

2026 · 2 citations

Ultra-trace Determination of Chromium (III) and Cobalt (II) Using Phosphonate Ester-Functionalized PAMAM Magnetite and DSPE-FAAS

Bulletin of Environmental Contamination and Toxicology

2026 · 2 citations

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit

Journal of Antimicrobial Chemotherapy

2026 · 1 citations

Reliability assessment of markerless technologies in biomechanical motion analysis: a performance comparison

Frontiers in Sports and Active Living
All articles